Product

QLF32101

1 clinical trial

1 indication

Indication

Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinical trial

A Phase 1 Clinical Study on the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Status: Not yet recruiting, Estimated PCD: 2024-08-21